Characterization and impact of cuproptosis-associated genes and lncRNAs in lung adenocarcinoma prognosis and immunotherapy
Cuproptosis is a recently characterized form of regulated cell death with potential relevance to tumor immunity. This study developed a cuproptosis-related long non-coding RNA (Cupr-RL) signature for prognosis and computational prediction of immunotherapy response in lung adenocarcinoma (LUAD). Using The Cancer Genome Atlas (TCGA) cohort, nine prognostic Cupr-RLs were identified by least absolute shrinkage and selection operator and Cox regression analyses, and a risk-score model was constructed and internally validated. The model stratified patients into high- and low-risk groups with significantly different overall and progression-free survival. AC084871.3, a high-risk Cupr-RL, was further evaluated by reverse transcription quantitative polymerase chain reaction and fluorescence in situ hybridization. Functional enrichment, tumor mutational burden, Tumor Immune Dysfunction and Exclusion, and immune-infiltration analyses indicated distinct molecular and immune features between the two risk groups and predicted greater potential benefit from immune checkpoint blockade in the low-risk group. Weighted gene co-expression network analysis and single-cell RNA sequencing identified NLRP3 as an immune-related hub gene associated with LUAD progression. These findings support the 9-Cupr-RL signature, AC084871.3, and NLRP3 as candidate prognostic and treatment-stratification biomarkers; prospective clinical validation is required before clinical application.
Authors
- Zhiyuan Chen (ORCID: https://orcid.org/0000-0002-6820-3678)
- Chen Luo
- Han Fu (ORCID: https://orcid.org/0009-0001-6655-0553)
- shuang sun
- Wei Zhao (ORCID: https://orcid.org/0000-0002-0112-5580)
- Zirui Wang
Institutions
- Chinese PLA General Hospital (CN)
- Community Health Center (US)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1007/s12672-026-06117-3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00